Because I spent 45 years of my life as a "full stack" developer I'm comfortable with various types of screen scraping and designing questions for AI and google search. I post my AI answers, not so much because I believe the answers but to prompt responses - some of which have turned out to be useful for me and others. However some followers can get a bit "lemming like" 😀 in topics they discuss so its good (I think) to get outside views.
It's still research. If it helps with your decisions, then it's another tool to be deployed. Be cautious when using it, as it can produce fake material that appears genuine. I have experienced incidents: A fake SBTX RNS that could have fooled some investors, especially new ones. Another provided an LA Times link to a greenwashing article, naming a US Corp that was fined. Again, it was fake. That's pretty serious. However, the major plus for me is avoiding the use of Google. I no longer have to suffer their ideology when researching, that's fantastic as far as I'm concerned.
All views are welcome as far as I am concerned. I just filter out the abusive and disruptive people.
Croda could be in a predicament, if they were to make a bid, they would not be alone. Zenakine, as the cosmetic giants are all too aware is the new watchword in skin care. I cannot see Sbtx going that cheaply, with a product in such demand. Winnifrith has got this completely wrong, a bid surely must be coming.
Ref NDA running on past the launch: PJ has arrived at a very plausible conclusion, which fits with Ashman's suggestion that it could be lifted soon, presumably within three months. Perhaps it covers the ongoing extension to the "smart partnership" beyond cosmetics. Ashman intimated that discussions were ongoing and suggested there could be other opportunities beyond Croda, being prudent.
I will be recording another podcast TOMORROW with an ex-BOARD member at IBM, and the head of MBO. Hopefully, I don't make a tit of myself.
Really enjoyed the discussion about the companies between the three of you today many thanks. I certainly believe that Zenakine in effects is just too good and that Croda will take us out shortly. The extended NDA contract by non disclosure of hard earnings in effect will depress the share price and its effect on SA means he cannot reveal size of order pipeline to his own shareholders which effectively also blinker them and help keep prices depressed which is the intension of Croda so they can obtain us at cheapest price. It’s forums like these and others that can share information which aids shareholders as effectively our CEO has his hands tied. Please keep up the great coverage
At this stage, it is all hypothetical. I keep asking myself why the NDA remains in effect after the launch. It coincided with the 12-month anniversary of the forward selling, which we now know is part of a contract with the VIP and therefore has specific significance. It is pure speculation; it could be a period designed to provide Croda with analytical data that would help them gauge interest in Zenakine, plus its value, which would, of course, be multiples as its global uptake grows. The bellweathers will be the VIPs. Has Croda hatched a cunning strategic plan?
Selfishly, I hope the share price doesn't spike on TO speculation- I haven't sold our house yet. :)
I really enjoyed PJ and Toyin chipping in. It was a really good discussion. PJ comment about comments on forums is spot on. I include myself as i know i can get my draws twisted sometimes.
I wouldn't welcome a bid for Sbtx nor do i think one will happen any time soon. You guys are far ahead of me in terms as competence, so ill bow to your wisdom.
Thanks for a bank holiday podcast. It was really encouraging. I must have a closer look at Insig. Although i do struggle to understand what it does.
Guys, great podcast and interesting times ahead. It's inevitable that Skin will get taken out, just a question of when and at what price. This blockbuster product is far better than anybody (including you Bill) imagined. Croda will not want to be paying royalties for too long whilst they can pick up the company relatively cheap. The higher the SP can rise short term, the better for us as there will need to be a premium. This could move quite quickly once some news breaks. By the way Bill how's life on your super yacht in the Bahamas? I assume that's where successful investors like yourself retire to🛥.
Thoroughly enjoyed the podcast and thanks to all for finding the time to participate.
One observation is that SA has repeatedly said that the financial position WITHOUT Croda revenue is enough to see the Company through to 2026 without the need for any fund raise, and I got the impression that Toyin felt that that it is only with the already received Croda revenues that has been possible; not sure that is correct at all.
The implication was that Dermatonics was due to surge in order to meet fy forecasts and that can only happen if Umesh Modi contributions rise exponentially through their now 8000 pharma distribution points and maybe an uptick in eoy NHS payments else SA would have to have stated "including Ctlroda royalty payments" surely?
Exact timing of comment "cash runway excluding Croda revenues expected to last through to Summer 2026" circa 8 mins 16 secs in. Now what is interesting, because I had overlooked the 4/12 RNS wording that certainly did need Croda revenues at that time to achieve the runway, is what has changed since? Warrants from Macq and I strongly suspect all have now been exercised securing £500k and increased margins from Dermatonics products now mixing the ingredients in-house plus maybe an uplift in sale price to the NHS noting the last uplift was Feb 24. Which also means by default that forward sales of Zenakine are likely to be in the £5m region generating at least £500k to SBTX bottom line.
So will Croda bid for Skinbiotherapeutics or will SA look to cut a deal where the skinbiotix limited cosmetic pillar is sold to them? After all we don't currently sell cosmetics only food supplements (Axisbiotix limited) , Medicines via Dermatonics products (Medibiotix Ltd) and Pharma products curtesy of the prescribed Once Heel Balm(Pharmabiotix Ltd). This would also lead tge SBTX group to obtain Zenakine at cost from Croda to create our own wound healing products with a partner
I have also been thinking about Croda taking SBTX out before we have realised our true potential.
I have personally spent years building a sizeable stake and would be seriously annoyed if we were taken out for 50p ish but Croda will ultimately be uncomfortable handed over growing sums of cash.
There are loads of options at 9p - see page 63 of the 30 June 2024 annual report. In total it notes over 16 million with an average exercise price of just 11p. Tom might therefore be right and 50p would make the board very rich despite not actually buying shares?
You are correct. SBTX has a large pool of share options outstanding from previous years, mainly at 9p and 18p per share. No new options were given out in 2024, and none were cancelled or exercised. These options are a tool to incentivise management and staff, but at the current share price (21.50p), suggests they are in the money if exercised. Why haven't they?
LOL. I guess the AI man is me (netcurtains).
Because I spent 45 years of my life as a "full stack" developer I'm comfortable with various types of screen scraping and designing questions for AI and google search. I post my AI answers, not so much because I believe the answers but to prompt responses - some of which have turned out to be useful for me and others. However some followers can get a bit "lemming like" 😀 in topics they discuss so its good (I think) to get outside views.
Hi John,
It's still research. If it helps with your decisions, then it's another tool to be deployed. Be cautious when using it, as it can produce fake material that appears genuine. I have experienced incidents: A fake SBTX RNS that could have fooled some investors, especially new ones. Another provided an LA Times link to a greenwashing article, naming a US Corp that was fined. Again, it was fake. That's pretty serious. However, the major plus for me is avoiding the use of Google. I no longer have to suffer their ideology when researching, that's fantastic as far as I'm concerned.
All views are welcome as far as I am concerned. I just filter out the abusive and disruptive people.
Good luck.
I’m at Wimbledon v Port Vale today… I should have worn a T-shirt saying zenakine 😀 (it’s on sky 12:30 kick off)
Give us a 👋
Motely crue is a rock band. Don't you mean Motely Fools before it closed its UK financial site a few years ago.
Company takeovers are very rare beasts
I think folk are getting well ahead of themselves
imho
Croda could be in a predicament, if they were to make a bid, they would not be alone. Zenakine, as the cosmetic giants are all too aware is the new watchword in skin care. I cannot see Sbtx going that cheaply, with a product in such demand. Winnifrith has got this completely wrong, a bid surely must be coming.
Ref NDA running on past the launch: PJ has arrived at a very plausible conclusion, which fits with Ashman's suggestion that it could be lifted soon, presumably within three months. Perhaps it covers the ongoing extension to the "smart partnership" beyond cosmetics. Ashman intimated that discussions were ongoing and suggested there could be other opportunities beyond Croda, being prudent.
I will be recording another podcast TOMORROW with an ex-BOARD member at IBM, and the head of MBO. Hopefully, I don't make a tit of myself.
Why change the habit of a lifetime?
Toyin, what message were you trying to send with the background? Sp?
Really enjoyed the discussion about the companies between the three of you today many thanks. I certainly believe that Zenakine in effects is just too good and that Croda will take us out shortly. The extended NDA contract by non disclosure of hard earnings in effect will depress the share price and its effect on SA means he cannot reveal size of order pipeline to his own shareholders which effectively also blinker them and help keep prices depressed which is the intension of Croda so they can obtain us at cheapest price. It’s forums like these and others that can share information which aids shareholders as effectively our CEO has his hands tied. Please keep up the great coverage
Hi Al,
At this stage, it is all hypothetical. I keep asking myself why the NDA remains in effect after the launch. It coincided with the 12-month anniversary of the forward selling, which we now know is part of a contract with the VIP and therefore has specific significance. It is pure speculation; it could be a period designed to provide Croda with analytical data that would help them gauge interest in Zenakine, plus its value, which would, of course, be multiples as its global uptake grows. The bellweathers will be the VIPs. Has Croda hatched a cunning strategic plan?
Selfishly, I hope the share price doesn't spike on TO speculation- I haven't sold our house yet. :)
I really enjoyed PJ and Toyin chipping in. It was a really good discussion. PJ comment about comments on forums is spot on. I include myself as i know i can get my draws twisted sometimes.
I wouldn't welcome a bid for Sbtx nor do i think one will happen any time soon. You guys are far ahead of me in terms as competence, so ill bow to your wisdom.
Thanks for a bank holiday podcast. It was really encouraging. I must have a closer look at Insig. Although i do struggle to understand what it does.
If this makes sense. I find it easier to concentrate on the benefits it gives rather than what it actually does.
Guys, great podcast and interesting times ahead. It's inevitable that Skin will get taken out, just a question of when and at what price. This blockbuster product is far better than anybody (including you Bill) imagined. Croda will not want to be paying royalties for too long whilst they can pick up the company relatively cheap. The higher the SP can rise short term, the better for us as there will need to be a premium. This could move quite quickly once some news breaks. By the way Bill how's life on your super yacht in the Bahamas? I assume that's where successful investors like yourself retire to🛥.
Thoroughly enjoyed the podcast and thanks to all for finding the time to participate.
One observation is that SA has repeatedly said that the financial position WITHOUT Croda revenue is enough to see the Company through to 2026 without the need for any fund raise, and I got the impression that Toyin felt that that it is only with the already received Croda revenues that has been possible; not sure that is correct at all.
The implication was that Dermatonics was due to surge in order to meet fy forecasts and that can only happen if Umesh Modi contributions rise exponentially through their now 8000 pharma distribution points and maybe an uptick in eoy NHS payments else SA would have to have stated "including Ctlroda royalty payments" surely?
I was going by the latest IM approx 6.53m in when Manprit clearly states cash runway without any Croda revenue will last until 2026
Exact timing of comment "cash runway excluding Croda revenues expected to last through to Summer 2026" circa 8 mins 16 secs in. Now what is interesting, because I had overlooked the 4/12 RNS wording that certainly did need Croda revenues at that time to achieve the runway, is what has changed since? Warrants from Macq and I strongly suspect all have now been exercised securing £500k and increased margins from Dermatonics products now mixing the ingredients in-house plus maybe an uplift in sale price to the NHS noting the last uplift was Feb 24. Which also means by default that forward sales of Zenakine are likely to be in the £5m region generating at least £500k to SBTX bottom line.
So will Croda bid for Skinbiotherapeutics or will SA look to cut a deal where the skinbiotix limited cosmetic pillar is sold to them? After all we don't currently sell cosmetics only food supplements (Axisbiotix limited) , Medicines via Dermatonics products (Medibiotix Ltd) and Pharma products curtesy of the prescribed Once Heel Balm(Pharmabiotix Ltd). This would also lead tge SBTX group to obtain Zenakine at cost from Croda to create our own wound healing products with a partner
Excellent podcast chaps.
I have also been thinking about Croda taking SBTX out before we have realised our true potential.
I have personally spent years building a sizeable stake and would be seriously annoyed if we were taken out for 50p ish but Croda will ultimately be uncomfortable handed over growing sums of cash.
Happy Easter
Barry
Elric,
Croda, could be forced into making a pre-emptive bid, and is extremely plausible and maybe imminent, unfortunately. A good showing from Toyin!
Just brilliant Chaps. Thank you very much.
There are loads of options at 9p - see page 63 of the 30 June 2024 annual report. In total it notes over 16 million with an average exercise price of just 11p. Tom might therefore be right and 50p would make the board very rich despite not actually buying shares?
You are correct. SBTX has a large pool of share options outstanding from previous years, mainly at 9p and 18p per share. No new options were given out in 2024, and none were cancelled or exercised. These options are a tool to incentivise management and staff, but at the current share price (21.50p), suggests they are in the money if exercised. Why haven't they?
Wow, some podcast!
Great podcast gents
Really enjoyed it
Sounded like Elric was enjoying his pint 😂😂